Back to Search
KEVIN LOOK, PHARMD
PHARMD
Pharmacist
NPI: 1851686851Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
15546-40(WI)
Research & Publications (20)
Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: a Gynecologic Oncology Group study.
PMID 16860852·Gynecol Oncol·2006
3-trial
Factors detracting students from applying for an obstetrics and gynecology residency.
PMID 16021092·Am J Obstet Gynecol·2005
4-observational
Phase II trial of liposomal doxorubicin at 40 mg/m(2) every 4 weeks in endometrial carcinoma: a Gynecologic Oncology Group Study.
PMID 15975638·Gynecol Oncol·2005
3-trial
Intraperitoneal radioactive phosphorus (32P) and vaginal brachytherapy as adjuvant treatment for uterine papillary serous carcinoma and clear cell carcinoma: a phase II Hoosier Oncology Group (HOG 97-01) study.
PMID 15721431·Gynecol Oncol·2005
3-trial
Role of lymphadenectomy in management of adenocarcinoma of the endometrium.
PMID 15493162·Eur J Gynaecol Oncol·2004
6-review
Phase II study of ifosfamide plus daily oral etoposide in previously treated ovarian cancer: a Hoosier Oncology Group (HOG) study.
PMID 15170139·Am J Clin Oncol·2004
3-trial
Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study.
PMID 15169803·J Clin Oncol·2004
3-trial
Cisplatin as initial chemotherapy in ovarian carcinosarcomas: a Gynecologic Oncology Group study.
PMID 15099942·Gynecol Oncol·2004
3-trial
Phase II trial of gemcitabine as second-line chemotherapy of uterine leiomyosarcoma: a Gynecologic Oncology Group (GOG) Study.
PMID 14766260·Gynecol Oncol·2004
3-trial
Phase I feasibility trial of carboplatin, paclitaxel, and gemcitabine in patients with previously untreated epithelial ovarian or primary peritoneal cancer: a Gynecologic Oncology Group study.
PMID 14751144·Gynecol Oncol·2004
3-trial
A randomized phase II evaluation of bryostatin-1 (NSC #339555) in recurrent or persistent platinum-sensitive ovarian cancer: a Gynecologic Oncology Group Study.
PMID 14578687·Invest New Drugs·2003
3-trial
Phase III trial of paclitaxel at two dose levels, the higher dose accompanied by filgrastim at two dose levels in platinum-pretreated epithelial ovarian cancer: an intergroup study.
PMID 12807937·J Clin Oncol·2003
3-trial
Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers.
PMID 12732731·Proc Natl Acad Sci U S A·2003
8-other
Phase I escalation of gemcitabine combined with protracted oral etoposide in gynecologic malignancies: A Gynecologic Oncology Group study.
PMID 12448655·Invest New Drugs·2002
3-trial
Phase I trial of paclitaxel and etoposide for recurrent ovarian carcinoma: a Gynecologic Oncology Group Study.
PMID 11202808·Am J Clin Oncol·2000
3-trial
Organ sparing management for carcinoma of the vulva & vagina.
PMID 11198029·Eur J Gynaecol Oncol·2000
6-review
Inverted follicular keratosis of the vulvar skin: a lesion that can be confused with squamous cell carcinoma.
PMID 11109167·Int J Gynecol Pathol·2000
5-case
The Society of Gynecologic Oncologists Outcomes Task Force. Study of endometrical cancer: initial experiences.
PMID 11104608·Gynecol Oncol·2000
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 201 JUNCTION RD
MADISON, WI 53717 - Phone
- (608) 827-9483
Quick Facts
- NPI
- 1851686851
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile